Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Sunve Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of chemical drugs and active pharmaceutical ingredients (APIs). The company focuses on several key therapeutic areas, including cardiovascular health, anti-infectives, and anti-inflammatory treatments. Sunve operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards, producing a wide range of oral solids and injectable formulations. Their product portfolio includes well-established treatments for hypertension and various bacterial infections, serving both domestic and international markets. The company is recognized for its integration of chemical synthesis and finished dosage form production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Sunve.